Evidence map›Paper›PMID 30652083›Full record

ArticleFEBS open bio2019

Coprs inactivation leads to a derepression of

Conception Paul, Hélène Delpech, Delphine Haouzi, Samir Hamamah, Claude Sardet, Eric Fabbrizio

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Conception PaulInstitut de Génétique Moléculaire de Montpellier UMR5535, CNRS, Montpellier University, France.
Hélène DelpechInstitut de Recherche en Cancérologie de Montpellier U1194, Inserm, ICM, CNRS, Montpellier University, Montpellier Cedex 5, France.
Delphine HaouziART-PGD Department, Institute of Regenerative Medicine and Biotherapy, CHU Montpellier, Inserm U1203, UFR of Medicine, Saint-Eloi Hospital, Montpellier University, France.
Samir HamamahART-PGD Department, Institute of Regenerative Medicine and Biotherapy, CHU Montpellier, Inserm U1203, UFR of Medicine, Saint-Eloi Hospital, Montpellier University, France.
Claude SardetInstitut de Recherche en Cancérologie de Montpellier U1194, Inserm, ICM, CNRS, Montpellier University, Montpellier Cedex 5, France.
Eric FabbrizioInstitut de Recherche en Cancérologie de Montpellier U1194, Inserm, ICM, CNRS, Montpellier University, Montpellier Cedex 5, France.
Inserm · FRCentre National de la Recherche Scientifique · FRDéveloppement Embryonnaire, Fertilité et EnvironnementUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Repression of retrotransposons is essential for genome integrity during germ cell development and is tightly controlled through epigenetic mechanisms. In primordial germ cells, protein arginine

Indexed as

AnimalsHistone ChaperonesLong Interspersed Nucleotide ElementsMaleMiceMice, KnockoutProtein-Arginine N-MethyltransferasesSpermatocytesSpermatogenesisCoprs protein, mouseHistone ChaperonesPrmt5 protein, mouseProtein-Arginine N-MethyltransferasescoprsMiwipiRNAspermatocyteteratozoospermiatestis

Identifiers

PMID30652083
PMCPMC6325579
OpenAlexW2903245047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.